Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Stichting Hemato-Oncologie voor Volwassenen Nederland
University Health Network, Toronto
Sun Yat-sen University
University of Arizona
Masonic Cancer Center, University of Minnesota
Institute of Hematology & Blood Diseases Hospital, China
City of Hope Medical Center